Chinese Journal of Tissue Engineering Research ›› 2020, Vol. 24 ›› Issue (35): 5715-5722.doi: 10.3969/j.issn.2095-4344.2879
Previous Articles Next Articles
Que Minqiang1, 2, Shi Chushuo1, Huang Yingjie1, Zhan Qunzhang1, Huo Chenxing1, Zhou Chi3, Yang Renxuan3
1Guangzhou University of Chinese Medicine, Guangzhou 510045, Guangdong Province, China; 2Guangzhou Orthopedic Hospital, Guangzhou 510045, Guangzhou Province, China; 3Zhuhai Hospital of Guangdong Traditional Chinese Medicine Hospital, Zhuhai 519000, Guangdong Province, China
Received:
2019-11-25
Revised:
2019-12-14
Accepted:
2020-01-17
Online:
2020-12-18
Published:
2020-10-19
Contact:
Yang Renxuan, MD, Chief physician, Zhuhai Hospital of Guangdong Traditional Chinese Medicine Hospital, Zhuhai 519000, Guangdong Province, China
About author:
Que Minqiang, Attending physician, Guangzhou University of Chinese Medicine, Guangzhou 510045, Guangdong Province, China; Guangzhou Orthopedic Hospital, Guangzhou 510045, Guangzhou Province, China
Supported by:
CLC Number:
Que Minqiang, Shi Chushuo, Huang Yingjie, Zhan Qunzhang, Huo Chenxing, Zhou Chi, Yang Renxuan. Network meta-analysis of different drugs for the treatment of primary osteoporosis[J]. Chinese Journal of Tissue Engineering Research, 2020, 24(35): 5715-5722.
2.5.3 网状Meta分析结果 由图16可得,与单纯唑来膦酸治疗相比较,除钙剂治疗、阿仑膦酸钠联合钙剂治疗和阿仑膦酸钠联合骨肽注射液治疗可显著减少不良反应的发生 (P < 0.05),其他药物治疗间差异均无统计学意义(P > 0.05)。与唑来膦酸联合钙剂治疗相比,除阿仑膦酸钠治和阿仑膦酸钠联合特立帕肽注射液治疗差异无统计学意义外(P > 0.05),钙剂治疗、阿仑膦酸钠联合钙剂治疗、阿仑膦酸钠联合骨肽注射液治疗均可显著降低不良反应的发生 (P < 0.05)。与单纯钙剂治疗相比,阿仑膦酸钠治疗、阿仑膦酸钠联合特立帕肽注射液治疗降低不良反应效果比钙剂治疗差,其他治疗均不能有效降低不良反应发生率(P < 0.05)。与单纯阿仑膦酸钠治疗相比,除阿仑膦酸钠联合特立帕肽注射液治疗差异无统计学意义外(P > 0.05),阿仑膦酸钠联合钙剂治疗和阿仑膦酸钠联合骨肽注射液治疗均可降低不良反应的发生(P < 0.05)。与阿仑膦酸钠联合特立帕肽注射液治疗比较,阿仑膦酸钠联合钙剂和阿仑膦酸钠联合骨肽注射液可降低不良反应发生(P < 0.05)。其中,阿仑膦酸钠联合钙剂降低不良反应发生的效果比阿仑膦酸钠联合骨肽注射液效果好(P > 0.05),差异无统计学意义。 "
[1] 单祎娜,王莉.骨质疏松症诊断和治疗进展[J].医学综述,2019,25(18): 3652-3656+3661.
[2] 杨丰文,张俊华,张伯礼.中医药网状Meta分析质量评价[J].中华中医药杂志,2018,33(10):4599-4606.
[3] 原发性骨质疏松症诊疗指南(2017)[J].中华骨质疏松和骨矿盐疾病杂志, 2017,10(5):413-444.
[4] 张春然.唑来膦酸与阿仑膦酸钠治疗老年骨质疏松症的效果研究[J].中国现代药物应用,2019,13(21):176-177.
[5] 马远征,王以朋,刘强,等.中国老年骨质疏松症诊疗指南(2018)[J].中国骨质疏松杂志,2018,24(12):1541-1567.
[6] 原发性骨质疏松症诊治指南(2011年)[J].中华骨质疏松和骨矿盐疾病杂志,2011,4(1):2-17.
[7] 刘志国,杨伟兵,张勇智,等.阿仑磷酸钠及唑来膦酸治疗原发性骨质疏松症患者的临床疗效观察[J].贵州医药,2019,43(1):96-97.
[8] 刘吉泉.阿仑膦酸钠及唑来膦酸治疗原发性骨质疏松症的临床价值分析[J].中国医药指南,2019,17(24):46-47.
[9] 邵志伟.阿仑膦酸钠及唑来膦酸治疗原发性骨质疏松症患者的临床效果分析[J].中国实用医药,2018,13(26):15-17.
[10] 黄从伍,何绮霞.鲑鱼降钙素联合唑来膦酸注射液和单纯阿仑膦酸钠治疗老年原发性骨质疏松症的效果对比[J].中医临床研究,2018,10(36): 133-135.
[11] 廖化波,张俊娟.阿仑膦酸钠联合骨肽治疗骨质疏松症患者的临床效果[J].中国骨质疏松杂志,2017,23(6):784-786.
[12] 冯嘉威.降钙素和双膦酸盐治疗原发性骨质疏松症的临床研究[J].吉林医学,2017,38(03):529-531.
[13] 李忠.分析阿仑膦酸钠及唑来膦酸治疗原发性骨质疏松症患者的临床疗效[J].当代医学,2017,23(24):22-24.
[14] 应小柏,涂琦.注射用骨肽联合阿仑膦酸钠片治疗原发性骨质疏松症的疗效观察[J].中国医院用药评价与分析,2017,17(11):1484-1485+1488.
[15] 张殿乙,李雅男,张楠.特立帕肽联合阿仑膦酸钠治疗绝经后骨质疏松症的临床研究[J].现代药物与临床,2016,31(8):1231-1235.
[16] 张辉.用骨肽注射液治疗原发性骨质疏松症的疗效研究[J].当代医药论丛, 2014,12(16):221-222.
[17] 蔡思林.唑来膦酸治疗原发性骨质疏松症疗效观察[J].中国现代药物应用, 2014,8(6):174-175.
[18] 杨敏,刘佳,范茂丹,等.唑来膦酸治疗原发性骨质疏松症的效果观察[J].现代生物医学进展,2013,13(3):533-535.
[19] 傅莉.鲑鱼降钙素注射液治疗原发性骨质疏松症82例效果观察[J].社区医学杂志,2012,10(24):3-4.
[20] 郭三忠,赵斌,谢振航.唑来膦酸治疗原发性骨质疏松症的疗效观察[J].中国骨与关节损伤杂志,2012,27(11):1037-1038.
[21] 黄宁庆,米桂芸,贡联兵,等.原发性骨质疏松症临床合理用药[J].人民军医, 2019,62(10):989-991.
[22] 吴红霞.原发性骨质疏松症患者抗骨质疏松治疗后骨密度及骨折率的变化分析[J].现代医用影像学,2019,28(1):87-88.
[23] 张杨.抗骨质疏松治疗对原发性骨质疏松症患者骨密度及骨折率的影响[J].世界最新医学信息文摘,2019,19(24):81+94.
[24] 梁伟东.对原发性骨质疏松症患者进行规范化抗骨质疏松治疗的效果探讨[J].当代医药论丛,2019,17(1):75-76.
[25] 马洁,宋燕青.骨肽注射液的临床应用及其药理作用[J].中国生化药物杂志,2016,36(2):16. [26] 卜建龙,徐亮,张品一,等.不同用药方案阿仑磷酸钠治疗老年性骨质疏松症的临床疗效分析[J].中国骨质疏松杂志,2014,20(2):181. |
[1] | Hua Haotian, Zhao Wenyu, Zhang Lei, Bai Wenbo, Wang Xinwei. Meta-analysis of clinical efficacy and safety of antibiotic artificial bone in the treatment of chronic osteomyelitis [J]. Chinese Journal of Tissue Engineering Research, 2021, 25(6): 970-976. |
[2] | Wang Yujiao, Liu Dan, Sun Song, Sun Yong. Biphasic calcium phosphate loaded with advanced platelet rich fibrin can promote the activity of rabbit bone marrow mesenchymal stem cells [J]. Chinese Journal of Tissue Engineering Research, 2021, 25(4): 504-509. |
[3] | Li Xinping, Cui Qiuju, Zeng Shuguang, Ran Gaoying, Zhang Zhaoqiang, Liu Xianwen, Fang Wei, Xu Shuaimei. Effect of modification of β-tricalcium phosphate/chitosan hydrogel on growth and mineralization of dental pulp stem cells [J]. Chinese Journal of Tissue Engineering Research, 2021, 25(22): 3493-3499. |
[4] | Chen Song, He Yuanli, Xie Wenjia, Zhong Linna, Wang Jian. Advantages of calcium phosphate nanoparticles for drug delivery in bone tissue engineering research and application [J]. Chinese Journal of Tissue Engineering Research, 2021, 25(22): 3565-3570. |
[5] | Wei Qin, Zhang Xue, Ma Lei, Li Zhiqiang, Shou Xi, Duan Mingjun, Wu Shuo, Jia Qiyu, Ma Chuang. Platelet-derived growth factor-BB induces the differentiation of rat bone marrow mesenchymal stem cells into osteoblasts [J]. Chinese Journal of Tissue Engineering Research, 2021, 25(19): 2953-2957. |
[6] | Li Zihan, Yin Wen, Sun Wei, Zhu Kun, Shen Di, Liu Yujia. An 8-week aerobic exercise promotes the function of voltage-dependent potassium channel in mesenteric vascular smooth muscle from obese rats [J]. Chinese Journal of Tissue Engineering Research, 2021, 25(17): 2630-2635. |
[7] | Nie Jianhua, Cheng Jiang, Mo Jiaqi. Analysis of liquid-solid interaction during three-dimensional printing of medical amorphous calcium phosphate [J]. Chinese Journal of Tissue Engineering Research, 2021, 25(16): 2548-2553. |
[8] | Wang Yue, Wang Xinjun, Yuan Yinpeng, Wang Yuze. Mechanism of DAIa2GIP inhibiting mitochondrial apoptosis in chondrocytes [J]. Chinese Journal of Tissue Engineering Research, 2021, 25(11): 1652-1657. |
[9] | Zhao Binbin, Zhong Weijian, Ma Guowu, Li Yongqi, Wang Ning. Comparison of the osteogenic effect of three different bone graft materials [J]. Chinese Journal of Tissue Engineering Research, 2021, 25(10): 1507-1510. |
[10] | Yang Yanan, Li Junfeng, Wang Li, Liu Hengquan, Lai Xuefei . Calcium citrate: an interesting organic calcium biomedical material [J]. Chinese Journal of Tissue Engineering Research, 2021, 25(10): 1609-1615. |
[11] | Lin Ming, Pan Jinyong, Zhang Huirong. Knockout of NIPBL gene down-regulates the abilities of proliferation and osteogenic differentiation in mouse bone marrow mesenchymal stem cells [J]. Chinese Journal of Tissue Engineering Research, 2020, 24(7): 1002-1008. |
[12] | Zhang Shengmin, Liu Chao. Research progress in osteogenic differentiation of adipose-derived stem cells induced by bioscaffold materials [J]. Chinese Journal of Tissue Engineering Research, 2020, 24(7): 1107-1116. |
[13] | Jiang Biantong, Zhang Zhigang, Jin Xiu, Wang Haiye, Wu Yuchen, Zhang Caiyun. Effects of different calcium supplementation pathways on calcium ion in calcium-free regional citrate anticoagulation-continuous renal replacement therapy: study protocol for a prospective randomized cross-over trial [J]. Chinese Journal of Tissue Engineering Research, 2020, 24(5): 726-730. |
[14] | Li Yongtao, Song Wenhui, Liu Changwen, Liang Kaiheng, Zhang Kaixi, Liu Changfeng. Clinical efficacy of calcium sulphate/demineralized bone matrix versus bone allograft in anterior cervical discectomy and fusion [J]. Chinese Journal of Tissue Engineering Research, 2020, 24(34): 5478-5485. |
[15] | Liu Xin, Du Bin, Sun Guangquan, Cao Jinxing, Jiang Xiaohong. Porous beta-tricalcium phosphate-polypyrrole-biotin-icariin composite scaffold promotes recruitment of bone marrow mesenchymal stem cells [J]. Chinese Journal of Tissue Engineering Research, 2020, 24(34): 5532-5537. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||